Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10206049 | 0.83 | TRPA1 (0.44) | TAAR1SLC6A2TRPA1ACACBIDO1 | |
| SCHEMBL12197642 | 0.83 | TRPA1 (0.44) | TAAR1SLC6A2TRPA1ACACBIDO1 | |
| SCHEMBL8293621 | 0.83 | TRPA1 (0.44) | TAAR1SLC6A2TRPA1ACACBIDO1 | |
| SCHEMBL5728691 | 0.82 | ACACB (0.41) | TAAR1SLC6A2TRPA1ACACB | |
| SCHEMBL11573486 | 0.82 | CYP1A2 (0.48) | TAAR1SLC6A2TRPA1SLC6A3CYP1A2 | |
| SCHEMBL13643094 | 0.82 | ACACB (0.41) | TAAR1SLC6A2TRPA1ACACB | |
| SCHEMBL13003087 | 0.81 | TAAR1 (0.56) | TAAR1SLC6A2TRPA1SLC6A3CYP1A2 | |
| SCHEMBL27590846 | 0.81 | TAAR1 (0.56) | TAAR1SLC6A2TRPA1SLC6A3CYP1A2 | |
| SCHEMBL6817767 | 0.78 | BDKRB2 (0.44) | TAAR1ACACBIDO1HPGDCYP1A2 | |
| SCHEMBL5728985 | 0.77 | CYP2A6 (0.47) | TAAR1SLC6A2ACACBIDO1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7525001-B2 | Process for preparation of 2,6-dialkyltetralin | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2009-04-28 | — | — | US | disclosed |
| US-7525001-B2 | Process for preparation of 2,6-dialkyltetralin | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2009-04-28 | — | — | US | disclosed |
| US-7525001-B2 | Process for preparation of 2,6-dialkyltetralin | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2009-04-28 | — | — | US | disclosed |
| US-20060020153-A1 | Novel process for preparation of 2,6-dialkyltetralin | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION | 2006-01-26 | — | — | US | disclosed |
| WO-2006009346-A2 | NOVEL PROCESS FOR PREPARATION OF 2,6-DIALKYLTETRALIN | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2006-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020153-A1 | Novel process for preparation of 2,6-dialkyltetralin | DDT, MVD, DNPH1 | TAAR1 2897/4885SLC6A2 2270/4885TRPA1 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.